Arkolith/Insider Trading/ELVN/Form 4

Patel Anish

CHIEF OPERATING OFFICEREnliven Therapeutics, Inc. (ELVN) · full profile →Form 4 · filed Dec 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$140K
Net Open-Market Flow
-$140K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 8, 2025Sell(S)5K$20.76$103K265K
Dec 8, 2025Sell(S)2K$21.78$37K263K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001967163-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML